.jpg)
Emeritus Professor of Biostatistics
UAB School of Public Health
, Genzyme (Products/Services: No) (Consultant)Alexion (Products/Services: No) (Consultant)AMO Pharma (Products/Services: No) (Consultant)Antisense Therapeutics (Products/Services: No) (Consultant)Astra-Zeneca, (Products/Services: No) (Consultant)Avexis Pharmaceuticals (Products/Services: Yes) (Consultant)Biogen (Products/Services: No) (Consultant)Biolinerx, (Products/Services: Yes) (Consultant)Brainstorm Cell Therapeutics (Products/Services: Yes) (Consultant)Bristol Meyers Squibb/Celgene (Products/Services: No) (Consultant)Clinical Trial Solutions LLC (Products/Services: No) (Consultant)CSL Behring (Products/Services: No) (Consultant)Galmed Pharmaceuticals (Products/Services: Yes) (Consultant)Genentech (Products/Services: Yes) (Consultant)Green Valley Pharma (Products/Services: No) (Consultant)GW Pharmaceuticals (Products/Services: Yes) (Consultant)Horizon Pharmaceuticals, (Products/Services: No) (Consultant)Immunic (Products/Services: No) (Consultant)Klein-Buendel Incorporated (Products/Services: No) (Consultant, Independent Contractor)Mapi Pharmaceuticals L (Products/Services: No) (Consultant)Merck (Products/Services: No) (Consultant)Merck/Serono (Products/Services: No) (Consultant)Mitsubishi Tanabe Pharma Holdings (Products/Services: No) (Consultant)NHLBI (Protocol Review Committee) (Products/Services: No) (Consultant)Novartis, (Products/Services: No) (Consultant)Opko Biologics (Products/Services: No) (Consultant)Osmotica Pharmaceuticals (Products/Services: Yes) (Consultant)Perception Neurosciences (Products/Services: Yes) (Consultant)Protalix Biotherapeutics (Products/Services: No) (Consultant)Prothena Biosciences (Products/Services: No) (Consultant)Reata Pharmaceuticals (Products/Services: No) (Consultant)Recursion/Cerexis Pharmaceuticals (Products/Services: Yes) (Consultant)Regeneron (Products/Services: No) (Consultant)Roche (Products/Services: No) (Consultant)SAB Biotherapeutics (Products/Services: No) (Consultant)Sanofi-Aventis (Products/Services: No) (Consultant)University of Pennsylvania (Products/Services: No) (Consultant)University of Texas Southwestern (Products/Services: No) (Consultant)Visioneering Technologies (Products/Services: No) (Consultant)
Dr. Cutter is Professor Emeritus of Biostatistics at UAB. He has directed numerous coordinating centers. He is a member of numerous DSMBs and advisory committees for NIH, Pharmaceutical Companies and foundations. . He served on the International Clinical Trials Committee of the National MS Society and International Federation of MS Societies for over a decade as well as being on the editorial boards of the Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, the journal Neurology Clinical Practice as a contributing editor and an Associate Editor of Alzheimer’s Disease Translational Research. He is a member of the Statistics Editorial Board for the Journal of the American Society of Nephrology (JASN). He is a past President of the Consortium of MS Centers. He serves as a mentor on numerous K awards, PhD and master’s students and teaches in various national and international short courses.
Dr. Cutter has a major interest in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research. He has directed numerous coordinating centers of multiple NIH randomized trials: He directed the coordinating center for the Combination Therapy in MS (COMBIRx) Trial; most recently the Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis Complex and the randomized Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis (PREVeNT trial) both NINDS funded studies. He has been the Deputy Director of the Operations Center and Director of the Coordinating Center for Neurofibromatosis Consortium with 7 current ongoing trials. He directed the coordinating center for the NHLBI Chronic Hypertension in Pregnancy (CHAP) and the Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE) clinical trial funded by NHLBI. He was the PI of the completed Trial of Thymectomy plus Prednisone versus Prednisone alone in the treatment of non-thymomatous Myasthenia Gravis (MGTx). He is the immediate past Director of the NARCOMS multiple sclerosis patient registry and the Myasthenia Gravis patient registry. He is the Director, Biostatistics/Bioinformatics Resource (BBR) Core in the O’Brien Center for Acute Kidney Injury Research, UAB-USC (NIDDK), UAB (NIAID) . Served as Associate Director, National Center for High Impact Clinical Trials in Rehabilitation Medicine and currently co-chairs the Data Quality and Analysis Committee for the Molecular Transducers of Exercise (MoTrPac) study.
